Canadian supermarket giant Loblaw Cos announced late last week that it has earned regulatory approval for its $11.03 billion buyout of Shoppers Drug Mart, according to reports.
The transaction combines two of the nation’s top retailers, resulting in the operation of thousands of groceries and pharmacies across Canada.
But the deal was not cleared by Canada’s Competition Bureau without concessions. Loblaw reportedly agreed to divest 18 outlets and, additionally, the Bureau imposed restrictions on contracts made between the conglomerate and suppliers to safeguard against price-fixing, reports say.
While the Bureau did not elaborate on what those restrictions were, reports say Loblaw said the agreements focus on a program that promotes price-matching between rivals.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
US Steel and Nippon Steel Secure International Approvals for $14.9B Merger
May 30, 2024 by
CPI
EU Watchdog Mandates Boardroom Accountability for AI in Banks
May 30, 2024 by
CPI
Senate Democrats Urge DOJ Investigation into Alleged Big Oil Collusion
May 30, 2024 by
CPI
ConocoPhillips Acquires Marathon Oil for $22.5 Billion in Major Energy Sector Consolidation
May 29, 2024 by
CPI
Judge Denies Amazon’s Bid to Dismiss FTC Lawsuit Over Prime Membership Practices
May 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI